Lv2
200 积分 2025-01-09 加入
MDS-538 Real-World Safety Profile of Luspatercept: A Pharmacovigilance Analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS)
7天前
已关闭
Evaluation of the efficacy of cell-penetrating monoclonal antibodies targeting intracellular p-NLRP3S295 in alleviating hepatotoxicant-induced NAFLD
8天前
已完结
Protein and peptide-based renal targeted drug delivery systems
23天前
已完结
Targeting NLRP3/NLRP1 Inflammasomes: Preclinical Efficacy and Safety of INV-1498 for Osteoarthritis
28天前
已关闭
Validation of the 0–10 verbal numeric scale for assessment of pruritus severity in dogs
1个月前
已完结
Recent progress in tyrosine kinase 2 inhibitors for atopic dermatitis
1个月前
已完结
Rebound Effect in Left Ventricular Structure, Tissue Characteristics, and Function in HOCM After Mavacamten Discontinuation
1个月前
已完结
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
1个月前
已完结
Effects of dietary compounds on nuclear factor erythroid 2-related factor 2 (Nrf2) modulation in chronic kidney disease: a systematic review of clinical trials
2个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
2个月前
已完结
皖公网安备34019202002308
